Research Policies & Fees:
Budgeting Costs Under the UM Research Patient Care Agreement
After an institutional review of patient care related charges on federal grants that fall under our negotiated Research Patient Care Agreement* and related agency policy statements, we have affirmed that these expenses are exempt from indirect cost recovery.
Proposals have been submitted to federal agencies with these costs excluded from IDC recovery during the current fiscal year (FY12).
If you are working on a federal project (or any sponsored project recovering the full federal rate) and have expenses that are under the Research Patient Care Agreement, these costs should be reviewed back to 7/1/2011 to make sure that they are not recovering IDC in post award. Additionally, as you prepare proposals for external sponsors, please be sure to exclude costs under the agreement from the Modified Total Direct Cost (MTDC) base.
If you have any questions about the review of expenses on an active project, please contact your Fin Ops coordinator. If you are preparing a proposal or have questions about the impact to awarded budgets, you may contact Heather Offhaus of the Medical School Grant Review & Analysis Office (firstname.lastname@example.org, 734-763-4272).
*The rates in the Research Patient Care Agreement have been loaded into the clinical pricing tool and MBECT systems.
Note: On non-federal projects that are recovering less than our negotiated research rate (currently 55.5%), the MTDC and exclusions do not apply. For instance, projects termed clinical trials (Class Code 22200) would have no Research Patient Care exclusions, but are already able to use the substantially discounted recovery rates.
|posted October 2011